Quiflapon Sodium

N/A

Report date: 2022/05/18 11:41:24
NME

Base Information

Drug NameQuiflapon Sodium
Drug Alias Name喹夫拉朋钠quiflaponum喹夫拉朋L-686708MK-0591 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene inhibitors
TargetsLeukotriene
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksKEGG